Sixteen patients with severe pre-eclampsia had more IgG-containing and Clq-binding circulating soluble immune complexes than did 16 matched women with normal pregnancies. The clinical features of preeclampsia may be explained by damage due to such complexes, although raised complex levels were also present in a few women with normal pregnancies.
Introduction
Soluble immune complexes have been reported in the sera of women in normal pregnancy,' and these may arise from a physiological immunological reaction between mother and child. Immune complexes can, however, cause a wide range of diseases, depending on, for example, the amount and type of complex. Many of the features of pre-eclampsia might be explained by excess or qualitatively abnormal circulating soluble immune complexes.2 We have therefore measured IgG-containing and Clq-binding complexes in the sera of women with severe pre-eclampsia and closely matched women with normal pregnancies.
Patients and methods
Sixteen pregnant women with severe pre-eclampsia were studied at gestational ages ranging from 28 to 40 weeks. The criteria for diagnosis were: (a) Sixteen women with normal pregnancies (controls) were selected who matched the patients for gestational age and parity (except for one para 3 control who was matched with a para 4 patient).
Venous blood samples were allowed to clot at room temperature, separated within three hours, and stored in aliquots in liquid nitrogen until analysis. IgG immune complexes were measured by their inhibition of IgG latex agglutination by rabbit IgM anti-human IgG3; agglutination was measured by counting unagglutinated particles on an electronic counter. Clq-binding complexes were similarly measured using purified human Clq as the agglutinating reagent.3 Samples were analysed blind in duplicate and results were expressed as percentage inhibition of agglutination. In non-pregnant people levels of inhibition are considered significant only if they are 20 % or more.3
Results
All 16 patients with pre-eclampsia had detectable levels of IgG complexes, and inhibition of agglutination was greater than 20'% in 11 cases. Five controls had no detectable IgG complexes and only four had more than 200% inhibition (see table) . Similarly, 13 preeclamptic patients had raised levels of Clq-binding complexes compared with four controls. For both types of complexes mean titres were considerably higher in the patients than in the controls (P < 0-005; Wilcoxon's rank sum test). In the group as a whole the values of patients and controls overlapped, but most of the preeclamptic patients had higher values than their matched controls at each gestation studied.
Two patients who had very low levels of IgG complexes at 32 and 29 weeks' gestation (cases 2 and 3) had much higher levels of Clqbinding complexes (17.7 % and 33-2 % inhibition respectively).
Discussion
The cause of pre-eclampsia is unknown. It occurs predominantly in first pregnancies, and even a first trimester miscarriage is protective.4 This suggests that immunisation to fetal antigens may stimulate the maturation of maternal immune reactions that are necessary to prevent fetal allograft rejection. Pre-eclampsia may be caused by partial failure of these protective mechanisms.
Higher levels of circulating soluble immune complexes may not only be a marker of this relative failure but may also cause such clinical features of pre-eclampsia as the immunoglobulin and complement deposition in renal glomeruli,-the early activation of the coagulation system,6 platelet consumption,-and IgG depletion., The raised levels of immune complexes in normal pregnancies that have been observed by ourselves and others' support the view that circulating immune complexes are not in themselves necessarily pathological in human pregnancy. Immune complexes are, however, heterogenous in terms of immunoglobulin class, subclass, size, and complementbinding capacity as well as the antigen involved, and a detailed examination of these differences has yet to be made in pregnancy. Thus, in our two patients who had low levels of circulating IgG complexes associated with much greater Clq-binding the predominant antibody might have been IgM rather than IgG. Until the properties of the immune complexes in normal and pre-eclamptic pregnancies are better characterised, the significance and function of the complexes will not be understood. This problem is to be examined in the next phase of our investigations.
